Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 40, 2016 - Issue 6
55
Views
1
CrossRef citations to date
0
Altmetric
Short Communication

First Report of Hb Limassol [β8(A5)Lys→Asn; HBB: c.27G>C] from Odisha, India

, , , , , , , & show all
Pages 422-424 | Received 07 Oct 2016, Accepted 13 Nov 2016, Published online: 31 Mar 2017

References

  • Huehns ER. Diseases due to abnormalities of hemoglobin structure. Annu Rev Med. 1970;21:157–178.
  • Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233. Available from: http://globin.cse.psu.edu.
  • Kyrri A, Felekis X, Kalogerou E, et al. Hb Limassol [β8(A5)Lys→Asn]: a new hemoglobin variant. Hemoglobin. 2001;25(4):421–424.
  • Purohit P, Mashon RS, Patel S, et al. Clinical and molecular characterization of Hb Hofu in eastern India. Int J Lab Hematol. 2014;36(1):71–76.
  • Meher S, Dehury S, Mohanty PK, et al. Hb Tianshui (HBB: C.119A>G) in compound heterozygosity with Hb S (HBB: C.20A>T) from Odisha, India. Hemoglobin. 2016;40(4):270–272.
  • Patel S, Purohit P, Mashon RS, et al. The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab – a single centre experience in eastern India. Pediatr Blood Cancer. 2014;61(8):1341–1346.
  • Dehury S, Purohit P, Patel S, et al. Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ+ thalassemia with IVS1-5(G→C) mutation. Pediatr Blood Cancer. 2015;62(6):1017–1023.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.